Case Study

Catalent Biologics Installs Herma Labeling Machines To Meet Stringent Requirements

Source: HERMA
HERMA 132M

In the race to produce and package life-saving biologics, including COVID-19 vaccines, Catalent Biologics turned to HERMA for a rapid solution. Faced with a process that typically takes a year, HERMA delivered two high-performance 132M HC wrap-around labeling machines in just 14 weeks. This case study explores how HERMA, led by its US subsidiary and in close collaboration with German headquarters, navigated the challenges of expedited delivery, installation, and validation to meet Catalent's urgent needs. Discover how HERMA's innovative technology and proactive approach are accelerating the production of critical medications.

Read the full case study to learn more.

access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

HERMA